Effects of coconut oil on testosterone-induced prostatic hyperplasia in Sprague-Dawley rats (Q56906851)

1

0 references

Vivian Molina

2

0 references

Rosa Más

3

0 references

Daisy Carbajal

4

0 references

David Marrero

5

0 references

Víctor González

6

0 references

Eduardo Rodríguez

Journal of Pharmacy and Pharmacology

7

0 references

publication date

July 2007

0 references

published in

0 references

volume

59

0 references

issue

7

0 references

page(s)

995-999

0 references

cites work

Dihydrotestosterone and the concept of 5alpha-reductase inhibition in human benign prostatic hyperplasia

1 reference

https://api.crossref.org/works/10.1211%2FJPP.59.7.0012

Dihydrotestosterone and the role of 5 alpha-reductase inhibitors in benign prostatic hyperplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.59.7.0012

Saw palmetto for benign prostatic hyperplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.59.7.0012

A rational approach to benign prostatic hyperplasia evaluation: recent advances

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.59.7.0012

Effects of D-004, a lipid extract from Cuban royal palm fruit, on inhibiting prostatic hypertrophy induced with testosterone or dihydrotestosterone in a rat model: A randomized, controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.59.7.0012

Comparison of phytotherapy (Permixon) with finasteride in the treatment of benign prostate hyperplasia: a randomized international study of 1,098 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.59.7.0012

The role of dihydrotestosterone in benign prostatic hyperplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.59.7.0012

Medical therapy for benign prostatic hyperplasia: a review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.59.7.0012

Influence of fasting status on the effects of coconut oil on chick plasma and lipoprotein composition.

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.59.7.0012

Serenoa repens (Permixon) inhibits the 5alpha-reductase activity of human prostate cancer cell lines without interfering with PSA expression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.59.7.0012

Long-term treatment with finasteride in men with symptomatic benign prostatic hyperplasia: 10-year follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.59.7.0012

Review of recent placebo-controlled trials utilizing phytotherapeutic agents for treatment of BPH.

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.59.7.0012

Beneficial effects of virgin coconut oil on lipid parameters and in vitro LDL oxidation

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.59.7.0012

Drug therapy of benign prostatic hyperplasia syndrome with alpha 1-receptor blockers. Basic principles and clinical results

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.59.7.0012

Serenoa repens (Permixon). A review of its pharmacology and therapeutic efficacy in benign prostatic hyperplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.59.7.0012

Inhibition of type 1 and type 2 5alpha-reductase activity by free fatty acids, active ingredients of Permixon

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.59.7.0012

The role of 5-alpha-reductase inhibition as monotherapy in view of the MTOPS data

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2FJPP.59.7.0012